IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 116 filers reported holding IVERIC BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,325 | -31.2% | 33,700 | -57.4% | 0.01% | +100.0% |
| Q1 2023 | $1,926 | +445.6% | 79,200 | +380.0% | 0.00% | +50.0% |
| Q4 2022 | $353 | -99.9% | 16,500 | +13.8% | 0.00% | +100.0% |
| Q3 2022 | $260,000 | -3.7% | 14,500 | -48.4% | 0.00% | 0.0% |
| Q2 2022 | $270,000 | -45.0% | 28,100 | -3.8% | 0.00% | -50.0% |
| Q1 2022 | $491,000 | -4.5% | 29,200 | -5.2% | 0.00% | 0.0% |
| Q4 2021 | $514,000 | +2.8% | 30,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $500,000 | +240.1% | 30,800 | +31.6% | 0.00% | +100.0% |
| Q2 2021 | $147,000 | +12.2% | 23,400 | +10.4% | 0.00% | – |
| Q1 2021 | $131,000 | -10.3% | 21,200 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $146,000 | +22.7% | 21,200 | 0.0% | 0.00% | – |
| Q3 2020 | $119,000 | -34.3% | 21,200 | -40.4% | 0.00% | -100.0% |
| Q2 2020 | $181,000 | – | 35,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |